Order results by:
Issue | Title | |
Vol 13, No 4 (2017) | CLINICAL ADVANTAGES OF TELMISARTAN: FEATURES OF PHARMACOKINETICS, PHARMACODYNAMICS AND EFFECTS ON THE DAILY BLOOD PRESSURE PROFILE | Abstract similar documents |
O. D. Ostroumova, E. A. Smolyarchuk, O. V. Bondarec, E. E. Paleeva | ||
"... half-life of telmisartan, which retains its effect for more than 24 hours. This is especially important ..." | ||
Vol 16, No 4 (2020) | How to Choose the Optimal Single-Pill Combination of the First-Line Antihypertensive Drugs? The Benefits of Amlodipine and Telmisartan Combination | Abstract similar documents |
O. D. Ostroumova, A. I. Kochetkov, V. N. Butorov, I. F. Krotkova | ||
"... hours), and also a decrease in BP variability. Therefore, amlodipine/telmisartan SPC can effectively ..." | ||
Vol 15, No 6 (2019) | Current Trends in the Treatment of Hypertension: Focus on Improving Prognosis. The Capabilities of an Amlodipine/Telmisartan Single-Pill Combination | Abstract similar documents |
O. D. Ostroumova, A. I. Kochetkov | ||
"... blocker. In both classes, the reference and the best representatives include, respectively, telmisartan ..." | ||
Vol 11, No 6 (2015) | Cardiometabolic properties of telmisartan: new perspectives for use | Abstract similar documents |
O. M. Drapkina, E. I. Fomicheva | ||
Vol 8, No 2 (2012) | TELMISARTAN IN THE TREATMENT OF ARTERIAL HYPERTENSION. CASE STUDY | Abstract similar documents |
V. I. Podzolkov, A. I. Tarzimanova | ||
"... , are presented. The advantages of this drugs class are highlighted with the focus on telmisartan. Additionally ..." | ||
Vol 17, No 1 (2021) | Optimization of Pharmacotherapy Within the Framework of a Patient-oriented Approach in the Treatment of Hypertension in Multimorbidity Patients (Clinical Case and Literature Review) | Abstract similar documents |
O. D. Ostroumova, I. A. Alyautdinova, S. N. Litvinova, A. V. Arablinskij, A. A. Kirichenko | ||
"... example of the use of a fixed combination of angiotensin II receptor blocker telmisartan and calcium ..." | ||
Vol 18, No 6 (2022) | Clinical Efficacy and Tolerability of Antihypertensive Therapy with Single Pill Combinations of Telmisartan in Patients with Arterial Hypertension in Clinical Practice According to the ON TIME Observational Study | Abstract similar documents |
F. T. Ageev, M. D. Smirnova | ||
"... combinations (SPC) amlodipine + telmisartan and hydrochlorothiazide + telmisartan in clinical practice ..." | ||
Vol 15, No 4 (2019) | Antihypertensive and Target-Organ Protective Properties of Telmisartan and Hydrochlorothiazide Single-Pill Combination | Abstract similar documents |
O. D. Ostroumova, A. I. Kochetkov | ||
"... conditions according to the new guidelines. In this regard, SPC of telmisartan and hydrochlorothiazide (HCT ..." | ||
Vol 7, No 4 (2011) | SARTANS OF THE SECOND GENERATION: THERAPEUTIC POTENTIAL EXTENSION | Abstract similar documents |
S. V. Nedogoda | ||
"... Peculiarities of the treatment with angiotensin II receptor blocker telmisartan are analyzed ..." | ||
Vol 2, No 4 (2006) | FROM HOPE TRIAL TO ONTARGET TRIAL: THE «HOPE» TO REACH THE «TARGET» - TO IMPROVE PROGNOSIS IN HIGH RISK PATIENTS | Abstract similar documents |
Yu. M. Lopatin | ||
Vol 13, No 3 (2017) | ANGIOTENSIN RECEPTOR BLOCKERS WITH PLEIOTROPIC PROPERTIES: A NEW STANDARD IN CARDIOVASCULAR RISK MANAGEMENT AND TREATMENT OF HYPERTENSION | Abstract similar documents |
V. I. Podzolkov, M. V. Pisarev | ||
"... resistance, obesity, dyslipidemia is also covered. The evidence base for the use of telmisartan as a drug ..." | ||
Vol 16, No 2 (2020) | The Effects of Telmisartan and Its Combinations on Office Blood Pressure: Results of Prospective Observational Study TAINA | Abstract similar documents |
O. D. Ostroumova, A. I. Kochetkov, F. T. Ageev, G. S. Anikin, E. Kh. Akhmetzyanova, E. I. Bezuglova, A. B. Bekoeva, N. Yu. Borovkova, N. G. Vinogradova, E. V. Gorbunova, A. A. Goryacheva, E. S. Zhugrova, O. A. Kislyak, S. M. Klyashev, V. P. Kuzmin, A. A. Lipchenko, G. V. Matyushin, E. A. Mikhailova, V. A. Nevzorova, A. G. Obrezan, T. A. Petrichko, M. M. Petrova, A. N. Reider, A. N. Repin, V. I. Sadovoy, N. P. Sanina, A. E. Skripchenko, R. I. Stryuk, I. V. Faiyance, L. A. Khaisheva, N. R. Khasanov, R. A. Khokhlov, E. E. Tsareva, A. L. Cherkashina, I. I. Shaposhnik, I. A. Shelestova, R. N. Shepel, E. V. Shikh, D. A. Yakhontov | ||
"... Aim. To evaluate the effectiveness and safety of telmisartan, used in monotherapy ..." | ||
Vol 5, No 2 (2009) | EFFECT OF ANTIHYPERTENSIVE DRUGS ON QUALITY OF LIFE IN PATIENTS WITH ARTERIAL HYPERTENSION | Abstract similar documents |
G. F. Andreeva, A. D. Deev, V. M. Gorbunov | ||
"... and telmisartan during 1-3 months. 24-hour blood pressure (BP) monitoring, QoL was performed before and after ..." | ||
Vol 5, No 1 (2009) | EFFECT OF MORNING AND EVENING RAMIPRIL TAKING ON AMBULATORY BLOOD PRESSURE PROFILE IN PATIENTS WITH ARTERIAL HYPERTENSION | Abstract similar documents |
V. M. Gorbunov, E. J. Fedorova, A. D. Deev, E. V. Platonova, O. J. Isaikina | ||
"... indices. Analysis of peak and phase characteristics of 24 hour BP profile was used as well as standard ..." | ||
Vol 12, No 2 (2016) | COMPARATIVE PHARMACOKINETICS AND EFFECT ON THE HEMODYNAMICS OF ORIGINAL AND GENERIC NEBIVOLOL IN HEALTHY VOLUNTEERS | Abstract similar documents |
E. I. Bambysheva, K. V. Isaeva, M. M. Makhinova, D. T. Guranda, V. G. Belolipetskaya | ||
"... /2 30.84±10.78 vs 29.59±12.08 hours, respectively). Blood pressure reduction was slightly more ..." | ||
Vol 8, No 2 (2012) | COMPARISON OF PHARMACOKINETICS AND PHARMACODYNAMICS OF THE ORIGINAL AND GENERIC ENALAPRIL IN THE ELDERLY PATIENTS WITH ARTERIAL HYPERTENSION | Abstract similar documents |
O. P. Bobrova, M. M. Petrova | ||
"... in the blood plasma 5.42 (5.26–5.76) vs 4.88 (4.86–4.94) hours, respectively; p<0.001. Original enalapril ..." | ||
Vol 12, No 3 (2016) | THE PHARMACOKINETICS OF APIXABAN IN PATIENTS WITH CARDIOEMBOLIC STROKE IN ACUTE PHASE | Abstract PDF (Eng) similar documents |
A. V. Kryukov, D. A. Sychev, D. A. Andreev, A. V. Ryabova, N. P. Denisenko, M. A. Loskutnikov, O. I. Vinogradov, M. A. Domashenko | ||
"... .6 ng•h/mL (CV%=82), median Tmax 3 hours (min 1, max 4), mean t½ 16.9 h (SD 13.6). Negative correlation ..." | ||
Vol 15, No 2 (2019) | Cognitive impairment in patients with arterial hypertension: a relationship with the level and daily blood pressure profile and pathogenetic mechanisms | Abstract similar documents |
T. M. Ostroumova, V. A. Parfenov, O. D. Ostroumova | ||
"... , увеличение величины утреннего подъема АД. Патогенетические аспекты взаимосвязи когнитивных нарушений и АГ ..." | ||
Vol 16, No 5 (2020) | Pharmacokinetics and Pharmacogenetics of Apixaban | Abstract similar documents |
A. V. Savinova, M. M. Petrova, N. A. Shnayder, E. N. Bochanova, R. F. Nasyrova | ||
"... », «фармакокинетика», «фармакогенетика», «эффективность», «безопасность». Подробно рассмотрена фармакокинетика ..." | ||
Vol 17, No 1 (2021) | Pharmacokinetics and Pharmacogenetics of Dabigatran | Abstract similar documents |
A. V. Savinova, V. S. Dobrodeeva, M. M. Petrova, R. F. Nasyrova, N. A. Shnayder | ||
"... , лишен недостатков, свойственных антагонистам витамина К, но фармакокинетика и фармакогенетика ..." | ||
Vol 19, No 5 (2023) | Daily breakfast: will skipping a morning meal become a new prognostic marker? | Abstract similar documents |
O. B. Shvabskaia, N. S. Karamnova, O. M. Drapkina | ||
"... исследований, подтверждающие важность утреннего приема пищи для здоровья. В статье представлены данные о ..." | ||
Vol 7, No 1 (2011) | INFLUENCE OF CHRONOTHERAPY WITH DIFFERENT ANTIHYPERTENSIVE DRUGS ON CIRCADIAN BLOOD PRESSURE PATTERN | Abstract similar documents |
V. M. Gorbunov, E. Yu. Fedorova, A. D. Deev, O. Yu. Isaikina, V. G. Belolipetskaya, E. A. Zhabina | ||
"... ; 3.8-4.3 for morning BP surge. The t-values of office and 24-hour BP were low (0.2-1.7). Conclusion ..." | ||
Vol 13, No 5 (2017) | CHRONOTHERAPY OF HYPERTENSION: CURRENT STATE OF THE SCIENTIFIC PROBLEM | Abstract similar documents |
V. M. Gorbunov, E. Y. Fedorova, E. V. Platonova | ||
"... , and inconvenience of 48-hour BP monitoring. The currently available scientific information concerning advantages ..." | ||
Vol 9, No 3 (2013) | TRUE RESISTANCE AND PSEUDORESISTANCE TO ASPIRIN | Abstract similar documents |
A. I. Martynov, E. V. Akatova, I. V. Urlayeva, O. P. Nicolin | ||
Vol 1, No 2 (2005) | PHARMACOKINETIC RESEARCHES AND PRACTICAL MEDICINE | Abstract similar documents |
V. G. Belolipetskaya, Y. V. Sukhanov | ||
"... В статье в доступной для практических врачей форме даются основные понятия о фармакокинетике как о ..." | ||
Vol 11, No 1 (2015) | ON THE SELECTION OF DRUGS DOSAGE REGIMEN | Abstract similar documents |
E. N. Bochanova | ||
"... Описывается сложная система регуляции гемостаза, недостаточные сведения о фармакокинетике ..." | ||
Vol 4, No 1 (2008) | COMPARATIVE EFFICACY OF LONG-TERM ANTIHYPERTENSIVE MONOTHERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AT THE WORK PLACE | Abstract similar documents |
О. N. Antropova, I. V. Osipova, E. I. Kuznetzova, N. V. Piricova, I. I. Curbatova | ||
"... nebivolol (1 group), enalapril (2 group) or indapamide (3 group). 24-hour BP monitoring, echocardiography ..." | ||
Vol 19, No 5 (2023) | White coat effect in patients with hypertension | Abstract similar documents |
G. F. Andreeva, V. M. Gorbunov, D. N. Antipushina, E. V. Platonova | ||
Vol 13, No 5 (2017) | EFFECT OF LISINOPRIL ON 24-HOUR BLOOD PRESSURE AND ARTERIAL STIFFNESS IN PATIENTS WITH ARTERIAL HYPERTENSION AND RHEUMATOID ARTHRITIS | Abstract similar documents |
O. L. Sarkisova, N. V. Rebrova, I. I. Bogomolova, E. A. Anisimova, R. S. Karpov, V. F. Mordovin, T. G. Khruleva | ||
"... .5±5.5 mg per day. Mean dose of lisinopril was 12.2±9.8 mg/day. Office BP measurements, 24-hour ..." | ||
Vol 12, No 1 (2016) | Features of pharmacotherapy in the elderly patients. Introduction to the problem | Abstract similar documents |
E. A. Ushkalova, O. N. Tkacheva, N. K. Runikhina, N. A. Chukhareva, A. Yu. Bevz | ||
"... Обсуждаются особенности фармакотерапии пожилых пациентов. Представлены данные по фармакокинетике и ..." | ||
Vol 19, No 3 (2023) | Recurrent bleeding during standard anticoagulant therapy in comorbid patients with atrial fibrillation: a clinical case report | Abstract similar documents |
A. A. Kudriavtseva, E. V. Kolpachkova, Z. A. Gebekova, T. A. Sadulaeva, A. A. Sokolova, D. A. Napalkov | ||
Vol 19, No 5 (2023) | Pharmacogenetics and pharmacokinetics of rivaroxaban in patients with atrial fibrillation and chronic kidney disease | Abstract similar documents |
N. A. Shatalova, D. A. Sychev, K. B. Mirzaev, A. I. Kochetkov, E. Yu. Ebzeeva, V. B. Dashabylova, P. O. Bochkov, S. N. Tuchkova, S. V. Glagolev | ||
Vol 10, No 1 (2014) | CHANGES IN THE PARAMETERS OF 24-HOUR BLOOD PRESSURE MONITORING AND ARTERIAL STIFFNESS IN PATIENTS WITH HYPERTENSION AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE TREATED WITH VALSARTAN | Abstract similar documents |
N. A. Karoli, G. R. Dolishnya, A. P. Rebrov | ||
"... Aim. To study changes in the parameters of the 24-hour blood pressure (BP) monitoring and arterial ..." | ||
Vol 17, No 2 (2021) | Main Factors Related with the White Coat Effect Level in Patients with Arterial Hypertension and Bronchial Asthma | Abstract similar documents |
G. F. Andreeva, M. I. Smirnova, V. M. Gorbunov, A. S. Kurekhyan, Y. N. Koshelyaevskaya | ||
"... ), 24-hour monitoring ambulatory (ABPM), spirometry, clinical and biochemical blood tests, BA control ..." | ||
Vol 5, No 1 (2009) | CLINICAL SIGNIFICANCE OF HEART RATE VARIABILITY INDEXES DERIVED FROM 5-MINUTE AND 24-HOUR ECG RECORDINGS IN PATIENTS WITH RHEUMATOID ARTHRITIS | Abstract similar documents |
D. A. Anichkov, A. A. Platonova | ||
"... factors and RA clinical characteristics, laboratory tests, 5-min and 24-hour ECG recordings. We analyzed ..." | ||
Vol 12, No 6 (2016) | EFFECT OF AMLODIPINE ON CIRCADIAN RHYTHM OF BLOOD PRESSURE IN HYPERTENSIVE FEMALE PATIENTS WITH DIFFERENT PSYCHO-EMOTIONAL BACKGROUND | Abstract similar documents |
V. R. Veber, M. P. Rubanova, S. V. Zhmailova, P. M. Gubskaya, A. I. Vinogradov | ||
"... Aim. To study the changes in indicators of 24-hours blood pressure (BP) monitoring during ..." | ||
Vol 5, No 4 (2009) | EFFICACY AND SAFETY OF COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH RENOPARENCHYMAL ARTERIAL HYPERTENSION IN ACTUAL CLINICAL PRACTICE | Abstract similar documents |
N. J. Borovkova, N. N. Borovkov, T. I. Maslov | ||
"... blood pressure (BP) and 24-hour ambulatory BP monitoring (ABPM) were evaluated initially and in 12 ..." | ||
Vol 17, No 1 (2021) | Pharmacogenetics as a Way for Personalizing Diuretic Therapy: Focus on Torasemide | Abstract similar documents |
N. M. Gafurova, E. V. Shikh, O. D. Ostroumova | ||
"... особенности пациента. Фармакогенетика торасемида может иметь существенное значение для фармакокинетики и ..." | ||
Vol 4, No 3 (2008) | ESTIMATION OF CLINICAL AND PHARMACOKINETIC EQUIVALENCE OF ORIGINAL AND GENERIC CARVEDILOLS IN PATIENTS WITH HYPERTENSION OF 1-2 GRADES | Abstract similar documents |
E. I. Bambysheva, S. N. Tolpygina, D. F. Guranda, I. E. Koltunov, V. G. Belolipetskaja, S. J. Martsevich | ||
Vol 15, No 4 (2019) | Optimization of Pharmacotherapy with Direct Oral Anticoagulants: the Need to Choose the Right Dosage Regimen | Abstract similar documents |
A. I. Kochetkov, O. D. Ostroumova | ||
Vol 1, No 2 (2005) | ASSESSMENT OF RILMENIDINE EFFICIENCY IN PATIENTS WITH ARTERIAL HYPERTENSION WITH DETERIORATION OF DAILY PROFILE OF BLOOD PRESSURE | Abstract similar documents |
P. P. Tikhonov, L. A. Sokolova | ||
"... . Decrease in 24-hour BP, daytime and nighttime BP, burden with BP and BP variability during daytime ..." | ||
Vol 18, No 6 (2022) | Effect of ABCB1 Gene Carriage and Drug-Drug Interactions on Apixaban and Rivaroxaban Pharmacokinetics and Clinical Outcomes in Patients with Atrial Fibrillation and Deep Vein Thrombosis | Abstract similar documents |
L. V. Fedina, I. N. Sychev, T. D. Rastvorova, E. V. Strigunkova, A. A. Kachanova, Z. A. Sozaeva, P. O. Bochkov, A. V. Vardanyan, K. B. Mirzayev, D. A. Sychev | ||
"... Цель. Изучить влияние носительства гена ABCB1 и межлекарственных взаимодействий на фармакокинетику ..." | ||
Vol 4, No 2 (2008) | EFFECT OF GENES SLCO1B1 AND MDR1 POLYMORPHISM ON ATORVASTATIN PHARMACOKINETICS AND PHARMACODYNAMICS IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA: RESULTS OF PILOT PHARMACOGENETICS STUDY | Abstract similar documents |
A. V. Semenov, D. A. Sichev, V. G. Kukes | ||
"... Цель. Оценить влияние полиморфизма генов SLCO1B1 и MDR1 на фармакокинетику и фармакодинамику ..." | ||
Vol 5, No 5 (2009) | LONG-TERM THERAPY WITH INDAPAMIDE IN ELDERLY AND SENILE PATIENTS WITH HYPERTENSION: CARDIORENOPROTECTIVE EFFECTS AND INFLUENCE ON QUALITY OF LIFE | Abstract similar documents |
M. E. Statsenko, T. G. Sherbakova, S. V. Belenkova, O. E. Sporova | ||
"... . Reduction of average 24-hour, day and night BP, BP load, rate of morning BP rising was observed. Negative ..." | ||
Vol 14, No 6 (2018) | Different Types of Blood Pressure Variability in Hypertensive Patients with Chronic Lower Airway Diseases | Abstract PDF (Eng) similar documents |
M. I. Smirnova, V. M. Gorbunov, A. S. Kurekhyan, Ya. N. Koshelyaevskaya, A. D. Deev | ||
"... . The assessment of 24-hour BPV and mid-term BPV was based on ABPM and HBPM, respectively. Results. The BPV levels ..." | ||
Vol 13, No 4 (2017) | CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND ARTERIAL HYPERTENSION: VASCULAR WALL AS THE TARGET ORGAN IN COMORBID PATIENTS | Abstract similar documents |
N. A. Karoli, A. P. Rebrov | ||
"... .05), and hypoxemia (r=-0.76, p<0.01). We noted relationships between the parameters of 24-hour BP monitoring ..." | ||
Vol 13, No 4 (2017) | COMPARATIVE ANALYSIS OF THE EFFICACY OF FIXED-DOSE COMBINATIONS OF AMLODIPINE/LISINOPRIL AND BISOPROLOL/HYDROCHLORTHIAZIDE IN PATIENTS WITH ESSENTIAL ARTERIAL HYPERTENSION COMBINED WITH OBESITY AND OVERWEIGHT | Abstract similar documents |
O. D. Ostroumova, A. I. Kochetkov, M. V. Lopukhina | ||
"... with untreated HT, stage II, degree 1-2 (51.7% of men, aged 53.6±0.8 years) were examined. 24-hour BP monitoring ..." | ||
Vol 5, No 4 (2009) | BISOPROLOL EFFICACY IN PATIENTS WITH ARTERIAL HYPERTENSION ASSOCIATED WITH CARDIOPULMONARY DISEASES | Abstract similar documents |
G. N. Gorokchovskaya, M. M. Petina | ||
"... сердца. Более детально обсуждаются особенности применения бисопролола, обусловленные его фармакокинетикой ..." | ||
Vol 13, No 3 (2017) | PHARMACOGENETIC ASPECTS OF NEW ORAL ANTICOAGULANTS APPLICATION | Abstract similar documents |
A. V. Kryukov, D. A. Sychev, O. V. Tereshchenko | ||
"... антикоагулянтов, на фармакокинетику препаратов данной группы. В исследовании RE-LY у носителей полиморфизма rs ..." | ||
Vol 12, No 5 (2016) | Antiarrhythmic Drugs Use in Elderly Patients. Vaughan Williams Class III and IV Drugs | Abstract similar documents |
E. A. Ushkalova, S. K. Zyryanov, K. E. Zatolochina, A. P. Pereverzev, N. A. Chukhareva | ||
"... фармакокинетики, наличия сопутствующих заболеваний и лекарственных взаимодействий пожилые пациенты более уязвимы в ..." | ||
Vol 11, No 4 (2015) | INFLUENCE OF THE CYP3A4 ISOENZYME METABOLIC ACTIVITY AND CYP2C19 GENE POLYMORPHISMS ON CLOPIDOGREL ANTIPLATELET EFFECT IN PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING PERCUTANEOUS CORONARY INTERVENTION | Abstract PDF (Eng) similar documents |
K. B. Mirzaev, R. E. Kazakov, V. V. Smirnov, D. A. Andreev, D. A. Sychev | ||
"... через измерение отношения концентрации 6-β-гидроксикортизола к кортизолу (6-OHC/FC) в утренней моче ..." | ||
Vol 13, No 2 (2017) | OBJECTIVE AND SUBJECTIVE FACTORS OF MEDICAL DRUG CHOICE | Abstract similar documents |
E. B. Babanskaya, L. V. Menshikova | ||
"... препаратам являются недостаточными. Врачам необходима и интересна информация по фармакокинетике и ..." | ||
Vol 8, No 3 (2012) | THE EFFICACY OF COMBINED BIOMARKER TESTS IN EARLY DIAGNOSTICS OF ACUTE MYOCARDIAL INFARCTION AFTER CLINICAL SYMPTOMS ONSET: ROLE OF HEART-TYPE FATTY ACID-BINDING PROTEIN | Abstract similar documents |
O. V. Baturina, S. R. Gilyarevsky, I. M. Kuzmina, M. A. Godkov, E. V. Klychnikova | ||
"... coronary syndrome (ACS) during first 6 hours after ACS symptoms onset were enrolled into the study ..." | ||
Vol 14, No 6 (2018) | Effectiveness of Chrono-Pharmacotherapy Depending on the Salt Sensitivity of Patients with Arterial Hypertension and Diabetes Mellitus Type 2 | Abstract PDF (Eng) similar documents |
V. V. Skibitskiy, A. A. Kiselev, A. V. Fendrikova | ||
"... weeks of antihypertensive therapy, 24-hour blood pressure monitoring was performed, the indices ..." | ||
Vol 3, No 4 (2007) | EFFECTS OF AMLODIPINE, FOSINOPRIL AND METOPROLOL ON HEMODYNAMICS IN HYPERTENSIVE PATIENTS | Abstract similar documents |
A. L. Hohlov, M. I. Shunikova, A. Yu. Sosnin, I. N. Kagramanyan, L. A. Lisenkova | ||
"... на сосудистое ремоделирование. Метопролол уменьшал утренний подъем АД и частоту сердечных сокращений ..." | ||
Vol 20, No 3 (2024) | Theory and practice of selective imidazoline receptor agonist use in Russia | Abstract similar documents |
N. I. Gaponova, V. R. Abdrakhmanov | ||
"... повышенную вариабельность АД, способствуя нормализации суточного профиля АД, снижению утреннего подъема ..." | ||
Vol 18, No 6 (2022) | Natriuresis as a Way to Assess the Effectiveness of Diuretic Therapy for Acute Decompensated Heart Failure: Data from a Pilot Study | Abstract similar documents |
K. V. Charaya, D. Yu. Shchekochikhin, S. N. Tarasenko, N. A. Ananicheva, S. A. Sovetova, T. V. Soboleva, O. N. Dikur, A. I. Borenstein, D. A. Andreev | ||
"... hours after the first dose of a loop diuretic was administered in patients with acute decompensation ..." | ||
Vol 13, No 3 (2017) | EFFECT OF SACUBITRIL/VALSARTAN ON NATRIURESIS, DIURESIS AND BLOOD PRESSURE IN HYPERTENSIVE PATIENTS | Abstract similar documents |
Zh. D. Kobalava, S. V. Villevalde, I. A. Meray, O. I. Lukina | ||
"... in a double-blind,-randomized, cross-over study. The change in 24-hour diuresis and natriuresis, fractional ..." | ||
Vol 13, No 3 (2017) | EFFECT OF EPINEPHRINE ADMINISTRATION ON MYOCARDIAL REMODELING IN EXPERIMENTAL STUDY | Abstract similar documents |
V. R. Veber, S. V. Zhmailova, M. P. Rubanova, P. M. Gubskaya | ||
"... spaces in bothLV and RV myocardium increases first after single epinephrine injection (after 2 hours ..." | ||
Vol 7, No 5 (2011) | ARRESTING OF COMPLICATED HYPERTENSIVE CRISES IN THE PHYSICIAN’S PRACTICE: URAPIDIL VALUE AND STUDY RESULTS | Abstract similar documents |
G. P. Arutyunov, L. G. Oganezova | ||
"... in groups during 6 hours. Results. The frequency of target BP achievement in the urapidil treatment group ..." | ||
Vol 5, No 1 (2009) | CORRELATION OF STRUCTURAL AND FUNCTIONAL FEATURES OF LEFT VENTRICLE WITH AMBULATORY BLOOD PRESSURE MONITORING DATA IN PATIENTS WITH ESSENTIAL HYPERTENSION | Abstract similar documents |
O. M. Khromtsova, M. V. Arkhipov | ||
"... Aim. To evaluate the relationship of 24-hour blood pressure (BP) monitoring data with myocardial ..." | ||
Vol 17, No 3 (2021) | Causes, Predisposing Factors and Prevention Directions of Drug-induced Bradycardia (Based on the Results of the Hospital Register of Oardiac Medications Overdoses STORM) | Abstract similar documents |
N. N. Nikulina, S. V. Seleznev, M. B. Chernysheva, S. S. Yаkushin | ||
"... изменения их фармакокинетики. Различий по клинико-демографическим характеристикам пациентов и оказании ..." | ||
Vol 9, No 2 (2013) | COMPARISON OF HEART RATE VARIABILITY ADJUSTED FOR AGE AND HEART RATE IN WOMEN WITH RHEUMATOID ARTHRITIS AND WOMEN WITHOUT RHEUMATIC DISEASES | Abstract similar documents |
D. S. Novikova, T. V. Popkova, A. N. Gerasimov, A. V. Volkov, E. I. Nasonov | ||
"... Aim. To compare the 24-hour indicators of heart rate variability (HRV), adjusted for age and 24 ..." | ||
Vol 3, No 2 (2007) | ARTERIAL HYPERTENSION IN YOUNG PEOPLE: EFFICACY OF SYMPATHOLYTIC THERAPY | Abstract similar documents |
N. N. Nikitina, A. G. Avtandilov, K. R. Petrosyan, S. L. Petrosov | ||
"... Aim. To evaluate the effect of imidasoline agonist, rilmenidine (Albarel), on 24-hour blood ..." | ||
Vol 16, No 2 (2020) | The Effect of Pharmacological Preconditioning with Nicorandil before Elective Coronary Stenting on the Long-Term Prognosis of Patients with Stable Coronary Artery Disease | Abstract similar documents |
G. N. Soboleva, R. V. Gostishchev, A. N. Rogoza, T. I. Kotkina, A. N. Samko, Yu. A. Karpov | ||
"... ; on the day of PCI – 20 mg 2 hours before intervention and 10 mg 6-12 hours after PCI; over the next 30 days ..." | ||
Vol 12, No 2 (2016) | ESTIMATION OF HIGHLY SENSITIVE TROPONIN TESTS IN THE DIAGNOSIS OF ACUTE CORONARY SYNDROME | Abstract similar documents |
L. V. Kremneva, S. N. Suplotov, S. V. Shalaev | ||
"... consider a 3-hour algorithm for myocardial infarction (MI) diagnostic, recommended by the expert group ..." | ||
Vol 20, No 1 (2024) | Effectiveness of different treatment regimens of enhanced external counterpulsation in patients with stable coronary artery disease complicated by heart failure | Abstract similar documents |
A. S. Lishuta, O. A. Slepova, N. A. Nikolaeva, N. V. Khabarova, E. V. Privalova, Yu. N. Belenkov | ||
"... with different EECP treatment regimens for 12 months: Group 1 (n=40): course of 35 hour-long procedures; Group 2 ..." | ||
Vol 12, No 5 (2016) | Features of Modern Anticoagulant Therapy in Patients with Nonvalvular Atrial Fibrillation and Chronic Kidney Disease | Abstract similar documents |
I. S. Daabul, A. A. Sokolova, D. A. Napalkov | ||
"... , непредсказуемость фармакодинамики и фармакокинетики у отдельных пациентов) способствовали поиску новых, более ..." | ||
Vol 16, No 4 (2020) | Current Clinical and Pharmacological Approaches to the Prescription of Loop Diuretics in Patients with Chronic Heart Failure | Abstract similar documents |
N. M. Gafurova, E. V. Shikh, O. D. Ostroumova | ||
"... повышенным риском повторных госпитализаций. В фармакокинетики петлевых диуретиков существуют значительные ..." | ||
Vol 15, No 4 (2019) | Safety of Using Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Chronic Kidney Disease | Abstract similar documents |
V. I. Petrov, O. V. Shatalova, A. S. Gerasimenko, V. S. Gorbatenko | ||
"... антикоагулянтов, их фармакокинетика в той или иной мере меняется при снижении скорости клубочковой фильтрации, что ..." | ||
Vol 20, No 4 (2024) | Baxdrostat and finerenone: new aldosterone synthase-aldosterone-mineralocorticoid receptor hormonal system inhibitors for the drug treatment of resistant arterial hypertension | Abstract similar documents |
O. B. Kuzmin, N. V. Buchneva, V. V. Belyanin, V. V. Zhezha, M. V. Stolbova | ||
"... нарушенной функцией почек. В обзоре представлены данные об особенностях фармакодинамики и фармакокинетики ..." | ||
Vol 7, No 3 (2011) | COMPARATIVE EVALUATION OF THE ANTIHYPERTENSIVE EFFECT OF PERINDOPRIL AND LOSARTAN POTASSIUM IN PATIENTS WITH ARTERIAL HYPERTENSION AND STENOTIC CORONARY ATHEROSCLEROSIS BEFORE REVASCULARIZATION: AN OPEN RANDOMIZED COMPARATIVE STUDY | Abstract similar documents |
O. A. Osipova, N. N. Kurbakov, A. G. Ovsyannikov, M. A. Vlasenko | ||
"... to 50 mg 2 times a day. Duration of observation was 8 weeks. Results. Perindopril reduced 24-hour ..." | ||
Vol 18, No 4 (2022) | Pulmonary Vascular Thrombosis in COVID-19: Clinical and Morphological Parallels | Abstract PDF (Eng) similar documents |
O. Ya. Porembskaya, V. N. Kravchuk, M. I. Galchenko, R. V. Deev, M. Sh. Chesnokov, A. V. Avanesyan, K. V. Lobastov, S. N. Tsaplin, L. A. Laberko, V. S. Ermakov, O. V. Pashovkina, I. V. Schastlivtsev, S. A. Sayganov | ||
"... 06 hours, 6-12 hours, 12-18hours, 18-24 hours and more than 24 hours was12%, 14%, 62%, 5% and 7 ..." | ||
Vol 18, No 6 (2022) | The Pathogenetic Basis of the Action of Bempedoic Acid | Abstract similar documents |
A. S. Petrosyan, R. S. Rud', P. P. Polyakov, A. Kh. Kade, S. A. Zanin | ||
"... фармакодинамики и фармакокинетики бемпедоевой кислоты. В частности, после поступления в организм она должна быть ..." | ||
Vol 2, No 1 (2006) | ANTIHYPERTENSIVE TREATMENT WITH COMBINED DRUG OF LOSARTAN AND HYDROCHLOROTHIAZIDE | Abstract similar documents |
R. M. Linchak, K. M. Shumilova, A. D. Martinyuk, T. A. Gusaim, E. V. Semyonova, L. G. Zhirova, S. A. Boitsov | ||
"... , индекс времени АД и величина утреннего повышения АД (с 37,6±2,0 до 23,9±1,9 мм рт. ст., p<0,001). Через ..." | ||
Vol 8, No 5 (2012) | CLINICAL RESULTS OF THROMBOLYTIC THERAPY WITH ALTEPLASE AND TENECTEPLASE IN PATIENTS WITH MYOCARDIAL INFARCTION | Abstract similar documents |
L. A. Bondarenko, L. E. Rudakova, F. K. Rakhmatullov, T. P. Kostrikova, I. I. Kapustina | ||
"... analyzed. Results. The average time pain-thrombolysis was 2.7±0.22 hours. High efficacy of both ..." | ||
Vol 5, No 2 (2009) | THE STRUCTURE OF DRUG PRESCRIPTION IN ACUTE CORONARY SYNDROME WITHOUT ST SEGMENT ELEVATION ON THE FIRST DAY OF HOSPITAL THERAPY | Abstract PDF (Eng) similar documents |
O. V. Reshetko, N. V. Furman, R. M. Magdeev | ||
"... coronary syndrome (ACS) without elevation ST during first 24 hours. Results. Prescription of drugs ..." | ||
Vol 7, No 1 (2011) | RESULTS OF TENEKTEPLASE USE IN MASSIVE PULMONARY THROMBOEMBOLISM. CLINICAL CASE | Abstract similar documents |
R. Rajan, R. Natarajan, G. Vijayaraghavan | ||
"... within 24 hours after symptom onset. This is one of the first cases of effective application ..." | ||
Vol 17, No 2 (2021) | Safety and Effectiveness of Pharmacologic Conversion of Atrial Fibrillation and Flutter: Results of Multicenter Trial. Part I: Study Rationale, Design and Assessment of Effectiveness | Abstract similar documents |
N. Yu. Mironov, Yu. A. Yuricheva, V. V. Vlodzyanovskiy, S. F. Sokolov, Kh. M. Dzaurova, S. P. Golitsyn, Yu. V. Shubik, M. V. Berman, M. M. Medvedev, A. E. Rivin, D. S. Parkhomchuk, A. E. Barybin, D. А. Balandin, R. E. Batalov, D. S. Terekhov, I. V. Evstifeev, I. R. Kildeev, O. V. Pyataeva, S. A. Zenin | ||
"... endpoints: restoration of sinus rhythm (SR) within 24 hours after the start of infusion of the study drug ..." | ||
Vol 19, No 5 (2023) | Efficacy of azilsartan medoxomil in patients with hypertension and stable coronary artery disease in combination with type 2 diabetes | Abstract similar documents |
A. M. Kochergina, O. L. Barbarash | ||
"... Aim. To study the effect of azilsartan medoxomil (AZL-M) on the 24-hour blood pressure (BP ..." | ||
Vol 17, No 3 (2021) | New Possibilities in Quantitative Assessment of Albuminuria in Patients with Atrial Fibrillation and Chronic Kidney Disease | Abstract PDF (Eng) similar documents |
A. A. Sokolova, A. I. Skripka, I. I. Ivanov, V. V. Kogay, A. I. Listratov, A. A. Gindis, D. A. Napalkov | ||
"... -hours urine spots and chronic kidney disease (CKD) progression pace in patients with atrial fibrillation ..." | ||
Vol 12, No 3 (2016) | EFFECT OF OBSTRUCTIVE SLEEP APNEA SYNDROME ON ARTERIAL STIFFNESS IN PATIENTS AT HIGH CARDIOVASCULAR RISK | Abstract PDF (Eng) similar documents |
V. E. Oleynikov, N. V. Burko, L. I. Salyamova, K. A. Ziboreva | ||
"... ) <30 episodes per hour were included into group 1 and patients with AHI >30 episodes per hour ..." | ||
Vol 6, No 4 (2010) | COMPARISON OF CLINICAL EFFICACY OF ORIGINAL BISOPROLOL AND ITS GENERIC DRUG IN PATIENTS WITH STABLE ANGINA AND CONCOMITANT CHRONIC OBSTRUCTIVE PULMONARY DISEASE | Abstract similar documents |
N. Yu. Grigorieva, E. G. Sharabrin, A. N. Kuznetsov | ||
"... hours after bisoprolol taking, 24-hour electrocardiogram-monitoring, evaluation of respiratory function ..." | ||
Vol 9, No 6 (2013) | THROMBOLYSIS OR PRIMARY PCI FOR MYOCARDIAL INFARCTION WITH ST-SEGMENT ELEVATION? THE STREAM TRIAL (STRATEGIC REPERFUSION EARLY AFTER MYOCARDIAL INFARCTION) | Abstract similar documents |
V. A. Sulimov | ||
"... 1892 patients with STEMI diagnosed within 3 hours after onset of symptoms, and whom it was impossible ..." | ||
Vol 7, No 1 (2011) | ANTIARRHYTHMIC EFFICACY OF PROPAFENONE IN PATIENTS WITH PERSISTENT ATRIAL FIBRILLATION | Abstract similar documents |
R. D. Kurbanov, N. U. Zakirov, Sh. K. Azizov | ||
"... the fist administration and 2, 4, 8, 12, 24 hours and some next days after propafenone therapy start ..." | ||
Vol 20, No 1 (2024) | Effect of CYP3A4/5, ABCB1 gene polymorphisms on the residual equilibrium concentration of apixaban and bleeding in patients with non-valvular atrial fibrillation and deep vein thrombosis | Abstract similar documents |
l. V. Fedina, i. N. Sychev, K. V. Mirzaev, A. V. Vardanyan, S. V. Glagolev, A. A. Kachanova, P. O. Bochkov, R. V. Shevchenko, S. N. Tuchkova, I. V. Sychev, S. P. Abdullaev, D A. Sychev | ||
"... CYP3A4*22 (rs35599367) C>T, CYP3A5*3 A>G, ABCB1 (rs1045642) C>T не влияло на фармакокинетику ..." | ||
Vol 9, No 6 (2013) | DOES TREATMENT STRATEGY FOR ATRIAL FIBRILLATION INFLUENCE MYOCARDIAL CONTRACTILE FUNCTION? | Abstract PDF (Eng) similar documents |
V. I. Podzolkov, A. I. Tarzimanova, I. J. Loriya, L. N. Mokhammadi | ||
"... into the study. Sinus rhythm (SR) was restored during the first 24 hours of hospitalization in all the pa- tients ..." | ||
Vol 12, No 4 (2016) | Organoprotective effects of serelaxin in patients with severe decompensated heart failure | Abstract similar documents |
Z. D. Kobalava, S. V. Villevalde, A. E. Solov'jova, I. A. Merai | ||
"... on the heart, kidneys, liver. 48-hour serelaxin infusion in patient with ischemic cardiomyopathy and severe ..." | ||
Vol 4, No 5 (2008) | AMLODIPINE ADVANTAGES IN ARTERIAL HYPERTENSION THERAPY | Abstract similar documents |
V. M. Tsareva, N. J. Hozjainova, M. S. Bezaltynnyh, T. V. Brook, N. A. Borohova, I. E. Koltunov, N. M. Ahmedzhanov | ||
"... (5-10 mg/day) therapy was started. ABPM, 24 hour electrocardiogram monitoring, echocardiography ..." | ||
Vol 12, No 3 (2016) | THE PREDICTION OF ATRIAL FIBRILLATION RECURRENCE AT VARIOUS METHODS OF SINUS RHYTHM RECOVERY | Abstract PDF (Eng) similar documents |
T. Y. Gromyko, S. A. Sayganov | ||
"... rhythm recovery. Material and methods. Patients (n=153) with nonvalvular AF lasting from 24 hours to 6 ..." | ||
Vol 8, No 6 (2012) | MODERN VIEWS ON THE VARIABILITY OF BLOOD PRESSURE | Abstract similar documents |
V. M. Gorbunov | ||
"... ) or more complex formulas, including SD. BPV main varieties are considered a 24-hour BPV (measured ..." | ||
Vol 6, No 1 (2010) | ACTOVEGIN INFLUENCE ON METABOLIC AND VASOMOTOR FUNCTION OF MICROVASCULAR ENDOTHELIAL OF HUMAN SKIN | Abstract similar documents |
A. A. Fedorovich, A. N. Rogoza, E. M. Kanisheva, S. A. Boytsov | ||
"... .v. during 2 hour infusion through the left cubital vein. Right forearm skin laser Doppler flowmetry (LDF ..." | ||
Vol 13, No 3 (2017) | ACUTE ATORVASTATIN RECAPTURE THERAPY IN CORONARY ARTERY BYPASS GRAFTING | Abstract similar documents |
A. V. Panov, M. L. Gordeev, A. A. Zhloba, T. F. Subbotina, I. V. Suhova, M. I. Buthashvili, I. T. Abesadze, M. Z. Alugishvili, N. L. Lohovinina, K. V. Korzhenevskaya, M. V. Solovyova, L. V. Mihaylova, E. S. Alekseevskaya | ||
"... 80 mg for 12 hours and 2 hours before CABG in patients previously treated with atorvastatin 20 mg/day ..." | ||
Vol 7, No 5 (2011) | A COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF ANTIANGINAL DRUGS OF DIFFERENT GROUPS — NITROVASODILATATOR (ISOSORBIDE-5-MONONITRATE SUSTAINED RELEASE) AND BETA-BLOCKER WITH VASODILATING ACTION (NEBIVOLOL) — IN PATIENTS WITH STABLE ANGINA | Abstract similar documents |
S. Yu. Martsevich, N. P. Kutishenko, V. A. Egorov, A. V. Zagrebel'nyy, A. A. Serazhim, Yu. V. Lukina, N. A. Dmitrieva | ||
"... decreased 2 hours after nebivolol intake both single one and after 30 days of treatment (p<0.001). Duration ..." | ||
Vol 6, No 6 (2010) | PROGNOSTIC VALUE OF PATHOLOGIC Q-WAVE AND TIME OF ITS APPEARANCE IN PATIENTS WITH MYOCARDIAL INFARCTION: COMPARISON STUDY | Abstract similar documents |
V. A. Shulman, S. E. Golovenkin, V. N. Simulin, V. V. Radionov, G. V. Matyushin | ||
"... appearance. First group consisted of 311 patients with early Q-wave (during first 6 hours from onset of MI ..." | ||
Vol 10, No 2 (2014) | CHANGE OF LOCAL MYOCARDIAL CONTRACTILITY DUE TO SELECTION OF DIFFERENT ARRHYTHMIA TREATMENT STRATEGIES IN PATIENTS WITH ISCHEMIC HEART DISEASE AND PAROXYSMAL ATRIAL FIBRILLATION | Abstract similar documents |
V. I. Podzolkov, A. I. Tarzimanova | ||
"... enrolled in the study. Sinus rhythm (SR) was restored during the first 24 hours after admission in all ..." | ||
Vol 14, No 2 (2018) | IMPACT OF LEVOSIMENDAN ON RENAL FUNCTION IN COMPLEX TREATMENT OF ACUTE DECOMPENSATED HEART FAILURE | Abstract similar documents |
M. V. Lediakhova, S. N. Nasonova, I. V. Zhirov, M. V. Andreevskaya, R. M. Bogieva, T. M. Uskach, M. A. Saidova, V. P. Masenko, S. N. Tereshchenko | ||
"... , the patients received an intravenous infusion of levosimendan 0.1 μg/kg/min for 24 hour added to standard ..." | ||
Vol 2, No 2 (2006) | CLINICAL EFFICACY AND PECULIARITY OF COMPLIANCE WITH 48-WEEK LONG THERAPY WITH EGILOK RETARD IN PATIENTS WITH MILD TO MODERATE HYPERTENSION | Abstract similar documents |
V. E. Oleynikov, V. A. Budanova, A. V. Kulucin | ||
"... with starting data on 48 week of treatment significant reduction in 24-hour , day and night systolic blood ..." | ||
Vol 12, No 1 (2016) | Characteristic features, treatment and hospital outcomes in patients with acute myocardial infarction: Khabarovsk Register data. Part I | Abstract similar documents |
L. N. Malay, L. V. Solokhina, Y. M. Bukhonkina, K. E. Poshatayev, H. B. Garayev, A. Ya. Letskin | ||
"... .19% of patients with a reference AMI admitted to the vascular center in the first 6 hours, and 65.39% of patients ..." | ||
Vol 20, No 2 (2024) | Comparative placebo-controlled study on the effect of dietary supplements containing omega-3 polyunsaturated fatty acids on hemodynamics and lipid metabolism in postmenopausal women | Abstract similar documents |
D. A. Napalkov, A. A. Sokolova, A. A. Kudrjavtseva, A. I. Skripka, A. V. Zhilenko, E. V. Kolpachkova, D. K. Varvarina | ||
"... (Omega-3 PUFAs) on the parameters of ambulatory blood pressure monitoring (ABPM), 24-hour ..." | ||
1 - 100 of 196 Items | 1 2 > >> |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)